199 related articles for article (PubMed ID: 11912107)
1. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease.
Tikka TM; Vartiainen NE; Goldsteins G; Oja SS; Andersen PM; Marklund SL; Koistinaho J
Brain; 2002 Apr; 125(Pt 4):722-31. PubMed ID: 11912107
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of CSF in motor neurone disease: a potential route to neuroprotection.
Shaw PJ
Brain; 2002 Apr; 125(Pt 4):693-4. PubMed ID: 11912105
[No Abstract] [Full Text] [Related]
3. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx.
Urushitani M; Nakamizo T; Inoue R; Sawada H; Kihara T; Honda K; Akaike A; Shimohama S
J Neurosci Res; 2001 Mar; 63(5):377-87. PubMed ID: 11223912
[TBL] [Abstract][Full Text] [Related]
4. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis.
Kruman II; Pedersen WA; Springer JE; Mattson MP
Exp Neurol; 1999 Nov; 160(1):28-39. PubMed ID: 10630188
[TBL] [Abstract][Full Text] [Related]
5. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.
Tikka T; Fiebich BL; Goldsteins G; Keinanen R; Koistinaho J
J Neurosci; 2001 Apr; 21(8):2580-8. PubMed ID: 11306611
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
7. Minocycline delays disease onset and mortality in a transgenic model of ALS.
Van Den Bosch L; Tilkin P; Lemmens G; Robberecht W
Neuroreport; 2002 Jun; 13(8):1067-70. PubMed ID: 12060810
[TBL] [Abstract][Full Text] [Related]
8. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia.
Tikka TM; Koistinaho JE
J Immunol; 2001 Jun; 166(12):7527-33. PubMed ID: 11390507
[TBL] [Abstract][Full Text] [Related]
9. Expressions of nitrotyrosine and TUNEL immunoreactivities in cultured rat spinal cord neurons after exposure to glutamate, nitric oxide, or peroxynitrite.
Manabe Y; Wang JM; Murakami T; Warita H; Hayashi T; Shoji M; Abe K
J Neurosci Res; 2001 Sep; 65(5):371-7. PubMed ID: 11536319
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of cerebrospinal fluid from motor neuron disease patients on the survival of primary motor neurons cultured with or without glia.
Barber SC; Wood-Allum CA; Sargsyan SA; Walsh T; Cox LE; Monk PN; Shaw PJ
Amyotroph Lateral Scler; 2011 Jul; 12(4):257-63. PubMed ID: 21366496
[TBL] [Abstract][Full Text] [Related]
11. Differential pattern of neuroprotection in lumbar, cervical and thoracic spinal cord segments in an organotypic rat model of glutamate-induced excitotoxicity.
Gerardo-Nava J; Mayorenko II; Grehl T; Steinbusch HW; Weis J; Brook GA
J Chem Neuroanat; 2013 Nov; 53():11-7. PubMed ID: 24126226
[TBL] [Abstract][Full Text] [Related]
12. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations.
Jacobsson J; Jonsson PA; Andersen PM; Forsgren L; Marklund SL
Brain; 2001 Jul; 124(Pt 7):1461-6. PubMed ID: 11408340
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
Sen I; Nalini A; Joshi NB; Joshi PG
J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
[TBL] [Abstract][Full Text] [Related]
14. The activation of spinal N-methyl-D-aspartate receptors may contribute to degeneration of spinal motor neurons induced by neuraxial morphine after a noninjurious interval of spinal cord ischemia.
Kakinohana M; Kakinohana O; Jun JH; Marsala M; Davison KJ; Sugahara K
Anesth Analg; 2005 Feb; 100(2):327-334. PubMed ID: 15673851
[TBL] [Abstract][Full Text] [Related]
15. AMPA receptor activation, but not the accumulation of endogenous extracellular glutamate, induces paralysis and motor neuron death in rat spinal cord in vivo.
Corona JC; Tapia R
J Neurochem; 2004 May; 89(4):988-97. PubMed ID: 15140197
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro.
Anneser JM; Chahli C; Borasio GD
Neuroscience; 2006 Sep; 141(4):1879-86. PubMed ID: 16820266
[TBL] [Abstract][Full Text] [Related]
17. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.
Casarejos MJ; Menéndez J; Solano RM; Rodríguez-Navarro JA; García de Yébenes J; Mena MA
J Neurochem; 2006 May; 97(4):934-46. PubMed ID: 16573651
[TBL] [Abstract][Full Text] [Related]
19. Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury.
Festoff BW; Ameenuddin S; Arnold PM; Wong A; Santacruz KS; Citron BA
J Neurochem; 2006 Jun; 97(5):1314-26. PubMed ID: 16638021
[TBL] [Abstract][Full Text] [Related]
20. Excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord.
Brunet N; Tarabal O; Esquerda JE; Calderó J
J Comp Neurol; 2009 Oct; 516(4):277-90. PubMed ID: 19634179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
